Trademark: 88077665
Status Date
Monday, August 15, 2022
Filing Date
Tuesday, August 14, 2018
Published for Opposition
Tuesday, November 13, 2018
Abandoned Date
Monday, August 15, 2022
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment of genetic diseases and disorders and pharmaceutical preparations for use in enzyme therapy
Aug 15, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 15, 2022
Abandonment - No Use Statement Filed
Jan 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2022
Sou Extension 5 Granted
Jan 6, 2022
Sou Extension 5 Filed
Jan 14, 2022
Case Assigned To Intent To Use Paralegal
Jan 6, 2022
Teas Extension Received
Jan 3, 2022
Assigned To Examiner
Jul 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 5, 2021
Sou Extension 4 Granted
Jul 5, 2021
Sou Extension 4 Filed
Jul 5, 2021
Teas Extension Received
Jan 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2021
Sou Extension 3 Granted
Jan 5, 2021
Sou Extension 3 Filed
Jan 5, 2021
Teas Extension Received
Jul 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 3, 2020
Sou Extension 2 Granted
Jul 3, 2020
Sou Extension 2 Filed
Jul 3, 2020
Teas Extension Received
Jan 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2020
Sou Extension 1 Granted
Jan 7, 2020
Sou Extension 1 Filed
Jan 7, 2020
Teas Extension Received
Jul 9, 2019
Noa E-Mailed - Sou Required From Applicant
May 30, 2019
Changes/Corrections After Pub Approval Entered
May 28, 2019
Assigned To Petition Staff
May 23, 2019
Extension Of Time To Oppose Process - Terminated
May 2, 2019
Teas Post Publication Amendment Received
Dec 12, 2018
Extension Of Time To Oppose Received
Nov 13, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 13, 2018
Published For Opposition
Oct 24, 2018
Notification Of Notice Of Publication E-Mailed
Sep 28, 2018
Approved For Pub - Principal Register
Sep 20, 2018
Assigned To Examiner
Aug 22, 2018
New Application Office Supplied Data Entered In Tram
Aug 17, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
